Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

Mapping Intimacies ◽

10.1111/dom.13859/v2/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v2/review1 ◽

2019 ◽

Author(s):

Yoshifumi Saisho

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Decision letter for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v1/review5 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v1/review4 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v1/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Author response for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v2/response1 ◽

2019 ◽

Author(s):

Hirotaka Watada ◽

Shizuka Kaneko ◽

Mitsuhisa Komatsu ◽

Bue Ross Agner ◽

Tomoyuki Nishida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Author Response ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v2/review4 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v2/review2 ◽

2019 ◽

Author(s):

Phil Ambery

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text

Review for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double‐blind, randomised trial"

10.1111/dom.13859/v1/review2 ◽

2019 ◽

Author(s):

Phil Ambery

Keyword(s):

Type 2 Diabetes ◽

Randomised Trial ◽

Fixed Ratio ◽

Insulin Degludec ◽

Phase 3 ◽

Double Blind ◽

Hba1c Control ◽

Japanese Subjects

Download Full-text